# Sunshine Biopharma Inc.: filings

SBFM · Nasdaq · CIK 1402328 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sbfm.md) · [Financials](/companies/sbfm/financials.md) · [Filings](/companies/sbfm/filings.md) · [Insiders](/companies/sbfm/insiders.md)

## Reports and events: 192 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 98, 10-Q 53, 4 40, CORRESP 19, 10-K 17, PRE 14C 15, UPLOAD 15, DEF 14C 14, 3 13, NT 10-Q 13, EFFECT 12, S-1 8, SCHEDULE 13G 7, 424B3 6, 4/A 6, NT 10-K 6, S-1/A 6, SCHEDULE 13G/A 6, 424B4 5, SC 13G 5, 8-K/A 4, D 4, DEF 14A 4, RW 4, S-3 4, 10-Q/A 2, 424B5 2, DEFA14A 2, DEFR14C 2, DRS 2, POS AM 2, PRE 14A 2, S-4 2, 10-KT 1, 3/A 1, 8-A12B 1, CERT 1, DEL AM 1, DRSLTR 1, S-8 1, SC 13G/A 1, SC 14F1 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 16:05 ET | [8-K](/filings/0001683168-26-007845.md) | 5.07 Shareholder vote results | 0001683168-26-007845 |
| 2026-10-09 | 17:25 ET | [8-K](/filings/0001683168-26-007758.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-007758 |
| 2026-10-02 | 16:49 ET | [S-1](/filings/0001683168-26-007581.md) | Registration statement | 0001683168-26-007581 |
| 2026-09-16 | 16:05 ET | [8-K](/filings/0001683168-26-007193.md) | 5.07 Shareholder vote results | 0001683168-26-007193 |
| 2026-09-11 | 17:00 ET | [8-K](/filings/0001683168-26-007090.md) | 8.01 Other events | 0001683168-26-007090 |
| 2026-08-28 | 16:15 ET | [S-1](/filings/0001683168-26-006779.md) | Registration statement | 0001683168-26-006779 |
| 2026-08-28 | 16:05 ET | [8-K](/filings/0001683168-26-006777.md) | 5.02 Departure or appointment of officers or directors | 0001683168-26-006777 |
| 2026-08-13 | 16:05 ET | [10-Q](/filings/0001683168-26-006340.md) | Quarterly report, period 2026-06-30 | 0001683168-26-006340 |
| 2026-08-03 | 08:52 ET | [8-K](/filings/0001683168-26-005899.md) | 8.01 Other events | 0001683168-26-005899 |
| 2026-07-20 | 16:27 ET | [8-K](/filings/0001683168-26-005656.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-26-005656 |
| 2026-07-10 | 16:54 ET | [8-K](/filings/0001683168-26-005458.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-26-005458 |
| 2026-05-29 | 16:05 ET | [8-K](/filings/0001683168-26-004387.md) | 5.07 Shareholder vote results | 0001683168-26-004387 |
| 2026-05-19 | 16:05 ET | [8-K](/filings/0001683168-26-004116.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-004116 |
| 2026-05-13 | 16:18 ET | [10-Q](/filings/0001683168-26-003819.md) | Quarterly report, period 2026-03-31 | 0001683168-26-003819 |
| 2026-05-12 | 16:16 ET | [S-1](/filings/0001683168-26-003726.md) | Registration statement | 0001683168-26-003726 |
| 2026-04-09 | 16:05 ET | [8-K](/filings/0001683168-26-002781.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-002781 |
| 2026-04-03 | 11:58 ET | [10-K](/filings/0001683168-26-002644.md) | Annual report, period 2025-12-31 | 0001683168-26-002644 |
| 2026-03-09 | 16:05 ET | [8-K](/filings/0001683168-26-001609.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-001609 |
| 2026-02-20 | 16:08 ET | [8-K](/filings/0001683168-26-001216.md) | 5.07 Shareholder vote results | 0001683168-26-001216 |
| 2026-02-05 | 16:16 ET | [8-K](/filings/0001683168-26-000789.md) | 5.02 Departure or appointment of officers or directors | 0001683168-26-000789 |
| 2025-12-12 | 16:05 ET | [8-K](/filings/0001683168-25-009103.md) | 5.07 Shareholder vote results | 0001683168-25-009103 |
| 2025-11-13 | 16:07 ET | [10-Q](/filings/0001683168-25-008328.md) | Quarterly report, period 2025-09-30 | 0001683168-25-008328 |
| 2025-10-23 | 16:56 ET | [DEF 14A](/filings/0001683168-25-007747.md) | Proxy statement, period 2025-12-11 | 0001683168-25-007747 |
| 2025-09-30 | 16:05 ET | [8-K](/filings/0001683168-25-007338.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001683168-25-007338 |
| 2025-08-12 | 16:56 ET | [10-Q](/filings/0001683168-25-005981.md) | Quarterly report, period 2025-06-30 | 0001683168-25-005981 |
| 2025-08-05 | 17:35 ET | [S-1](/filings/0001683168-25-005644.md) | Registration statement | 0001683168-25-005644 |
| 2025-05-19 | 17:06 ET | [8-K](/filings/0001683168-25-003838.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-003838 |
| 2025-05-15 | 16:06 ET | [10-Q](/filings/0001683168-25-003701.md) | Quarterly report, period 2025-03-31 | 0001683168-25-003701 |
| 2025-04-03 | 12:02 ET | [8-K](/filings/0001683168-25-002245.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-002245 |
| 2025-04-02 | 10:50 ET | [8-K](/filings/0001683168-25-002193.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-002193 |
| 2025-04-01 | 17:05 ET | [10-K](/filings/0001683168-25-002184.md) | Annual report, period 2024-12-31 | 0001683168-25-002184 |
| 2025-01-15 | 08:30 ET | [8-K](/filings/0001683168-25-000357.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-25-000357 |
| 2024-12-10 | 16:26 ET | [8-K](/filings/0001683168-24-008607.md) | 5.07 Shareholder vote results | 0001683168-24-008607 |
| 2024-11-07 | 16:40 ET | [8-K](/filings/0001683168-24-007758.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-007758 |
| 2024-11-05 | 16:05 ET | [10-Q](/filings/0001683168-24-007622.md) | Quarterly report, period 2024-09-30 | 0001683168-24-007622 |
| 2024-10-23 | 16:05 ET | [8-K](/filings/0001683168-24-007323.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-24-007323 |
| 2024-10-17 | 16:05 ET | [DEF 14A](/filings/0001683168-24-007196.md) | Proxy statement, period 2024-12-10 | 0001683168-24-007196 |
| 2024-09-10 | 16:05 ET | [8-K](/filings/0001683168-24-006281.md) | 8.01 Other events | 0001683168-24-006281 |
| 2024-08-20 | 16:05 ET | [10-Q/A](/filings/0001683168-24-005931.md) | Quarterly report, amended, period 2024-06-30 | 0001683168-24-005931 |
| 2024-08-19 | 16:05 ET | [8-K](/filings/0001683168-24-005903.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-005903 |
| 2024-08-16 | 17:00 ET | [10-Q](/filings/0001683168-24-005846.md) | Quarterly report, period 2024-06-30 | 0001683168-24-005846 |
| 2024-08-12 | 16:05 ET | [8-K](/filings/0001683168-24-005496.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-24-005496 |
| 2024-07-02 | 16:05 ET | [8-K](/filings/0001683168-24-004601.md) | 5.07 Shareholder vote results | 0001683168-24-004601 |
| 2024-07-01 | 16:05 ET | [8-K](/filings/0001683168-24-004572.md) | 8.01 Other events | 0001683168-24-004572 |
| 2024-06-11 | 16:00 ET | [8-K](/filings/0001683168-24-004120.md) | 8.01 Other events | 0001683168-24-004120 |
| 2024-06-07 | 16:00 ET | [8-K](/filings/0001683168-24-004053.md) | 3.01 Delisting notice | 0001683168-24-004053 |
| 2024-05-22 | 16:11 ET | [8-K](/filings/0001683168-24-003777.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-003777 |
| 2024-05-20 | 15:34 ET | [10-Q](/filings/0001683168-24-003688.md) | Quarterly report, period 2024-03-31 | 0001683168-24-003688 |
| 2024-05-08 | 16:21 ET | [8-K](/filings/0001683168-24-003104.md) | 4.01 Change of auditor | 0001683168-24-003104 |
| 2024-05-06 | 12:14 ET | [8-K](/filings/0001683168-24-003004.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001683168-24-003004 |

Page 1 of 4. [Older](/companies/sbfm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 12:16 ET. No prices; not investment advice.